Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)

ConditionInterstitial Lung Disease

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorMayo Clinic

About this trial

To develop a repository of blood samples from patients with ILD to support future studies into the development of such biomarkers. Patients with pneumonia and healthy patients will also be recruited as a control group.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Patients with a diagnosis of ILD or any fibrotic disease of the lung or a diagnosis of pneumonia

Patients willing to provide written informed consent

Disqualifiers

Unwillingness/unable to give blood samples

Trial population

Patients with a diagnosis of ILD or any fibrotic disease of the lung. A diagnosis of pneumonia and healthy volunteers will also be included as a control group.

Trial design

Design model

Other

Time perspective

Retrospective

Treatments tested in this trial

ILD
Other intervention
100 cc of blood collected from a total of 250 ILD patients. This includes IPF (n=100), fibrotic NSIP (n=50), chronic hypersensitivity pneumonia (n=20), sarcoidosis(n=50), progressive rheumatoid lung disease (n=10) and scleroderma lung disease (n=20)), 10 patients with other fibrosing disease (fibrosing mediastinitis), and 50 patients with lymphangioleiomyomatosis
Healthy
Other intervention
100 cc of blood collected from a total of 25 healthy volunteers in order to compare with the ILD participants.
Pneumonia
Other intervention
100 cc of blood collected from a total of 100 participants with a diagnosis of pneumonia in order to compare with the ILD participants.

Treatment groups

635 Participants

are divided into 3 treatment groups

Group A: ILD1 intervention

Group B: Healthy1 intervention

Group C: Pneumonia1 intervention

Trial outcomes

Primary outcomes

Future Disease Management

Reliable biomarkers to help guide treatment in ILD would be a major step forward in the management of this disease.

Time frame

1 visit

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Mayo Clinic

Lead sponsor

Source ClinicalTrials.gov

Apply now